Management of Hepatic Encephalopathy

Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. Reduction of plasma ammonia remains the central therapeutic strategy, but there is a need for newer novel therapies. We discuss current evidence supporting the use of int...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, G., Chattree, A., Jalan, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177461/
https://www.ncbi.nlm.nih.gov/pubmed/21994873
http://dx.doi.org/10.4061/2011/841407
_version_ 1782212303423275008
author Wright, G.
Chattree, A.
Jalan, R.
author_facet Wright, G.
Chattree, A.
Jalan, R.
author_sort Wright, G.
collection PubMed
description Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. Reduction of plasma ammonia remains the central therapeutic strategy, but there is a need for newer novel therapies. We discuss current evidence supporting the use of interventions for both the general management of chronic HE and that necessary for more acute and advanced disease.
format Online
Article
Text
id pubmed-3177461
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-31774612011-10-12 Management of Hepatic Encephalopathy Wright, G. Chattree, A. Jalan, R. Int J Hepatol Review Article Hepatic encephalopathy (HE), the neuropsychiatric presentation of liver disease, is associated with high morbidity and mortality. Reduction of plasma ammonia remains the central therapeutic strategy, but there is a need for newer novel therapies. We discuss current evidence supporting the use of interventions for both the general management of chronic HE and that necessary for more acute and advanced disease. SAGE-Hindawi Access to Research 2011 2011-09-21 /pmc/articles/PMC3177461/ /pubmed/21994873 http://dx.doi.org/10.4061/2011/841407 Text en Copyright © 2011 G. Wright et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wright, G.
Chattree, A.
Jalan, R.
Management of Hepatic Encephalopathy
title Management of Hepatic Encephalopathy
title_full Management of Hepatic Encephalopathy
title_fullStr Management of Hepatic Encephalopathy
title_full_unstemmed Management of Hepatic Encephalopathy
title_short Management of Hepatic Encephalopathy
title_sort management of hepatic encephalopathy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177461/
https://www.ncbi.nlm.nih.gov/pubmed/21994873
http://dx.doi.org/10.4061/2011/841407
work_keys_str_mv AT wrightg managementofhepaticencephalopathy
AT chattreea managementofhepaticencephalopathy
AT jalanr managementofhepaticencephalopathy

Ejemplares similares